Bill Faubion, M.D., discusses a recent study published in Nature Methods that examined the development of a stem cell line directly from the gut. The study describes an intestinal cell line generated from a mouse that hopes to provide new ways of treating IBD, such as replacing diseased or inflamed tissue with new tissue.
Dr. Faubion also discusses his research with stem cells derived from fat. The research tries to isolate fat derived stem cells to treat fistulizing Crohn's disease.
The full text of the article can be found here.
For more information on IBD, visit mayoclinic.org/ibd
Dr. Faubion is a gastroenterologist at Mayo Clinic specializing in the care of children and adults with inflammatory bowel disease.